lux-lung 7: phase 2b trial of first-line afatinib versus gefitinib for egfr mutation-positive nsclc
Published 8 years ago • 299 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
1:21
lux-lung 7: phase 2b trial of afatinib versus gefitinib for egfr-mutated lung cancer in first-line
-
1:31
lux-lung 7: phase 2b trial of afatinib versus gefitinib for egfr-mutated adenocarcinoma of the lung
-
1:35
afatinib for advanced egfrm-positive nsclc
-
17:27
how, when, and where to utilize erlotinib, afatinib, and gefitinib in egfr positive nsclc
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
3:38
overview of the world of egfr mutant lung cancers
-
6:43
sequential afatinib and osimertinib in egfr mutation-positive nsclc patients: updated results
-
0:51
dr. tianhong (tina) li reviews the lux-lung 3 trial afatinib data
-
6:57
周處除三害：肺癌用藥觀念的錯誤，看電影學習肺癌 the pig, the snake and the pigeon: lung cancer medication insights
-
14:23
treatment updates: egfr-mutant lung cancer | 2024 living with egfr-mutant lung cancer patient forum
-
5:32
introduction to egfr inhibitors
-
4:09
frontline afatinib in egfr-mutant nsclc
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
2:15
phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
3:07
efficacy and safety of afatinib vs erlotinib and gefitinib in egfr nsclc
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
58:47
15 years of advances in egfr mutant lung cancer
-
![afatinib treatment in squamous cell lung cancer – video abstract [id 104177]](https://i.ytimg.com/vi/_70TvE15WFw/mqdefault.jpg)
4:24
afatinib treatment in squamous cell lung cancer – video abstract [id 104177]
-
0:45
dr. corey langer discusses afatinib in egfr-positive nsclc
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
5:59
targeted therapy in consolidation setting for lung cancer